ANI Pharmaceuticals Inc (NAS:ANIP)
$ 56.15 1.83 (3.37%) Market Cap: 1.18 Bil Enterprise Value: 1.21 Bil PE Ratio: 48.83 PB Ratio: 2.59 GF Score: 86/100

Q4 2021 ANI Pharmaceuticals Inc Earnings Call Transcript

Mar 15, 2022 / 12:30PM GMT
Release Date Price: $29.01 (-18.65%)
Operator

Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. Fourth Quarter 2021 Earnings Results Call. (Operator Instructions) Please note this call may be recorded, and I will be standing by should you need any assistance.

It is now my pleasure to turn today's program over to Judy DiClemente.

Judy DiClemente

Thank you, Britney. Welcome to ANI Pharmaceuticals' Q4 2021 Earnings Results Call. This is Judy DiClemente of In-Site Communications, Investor Relations for ANI. With me on today's call are Nikhil Lalwani, President and Chief Executive Officer; and Stephen Carey, Chief Financial Officer of ANI. You can also access the webcast of this call through the Investors section of the ANI website at www.anipharmaceuticals.com.

Before we get started, I would like to remind everyone that any statements made on today's conference call that express a belief, expectation, projection, forecast, anticipation or intent regarding future events and the company's future performance

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot